Hyperbaric oxygen therapy improves clinical symptoms and functional capacity and restores thalamic connectivity in ME/CFS

- Posted by system in English

Significance of the topic: The topic of this study is the evaluation of hyperbaric oxygen therapy (HBOT) as a potential treatment for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). ME/CFS is a debilitating disorder with significant physical and cognitive impairments, affecting the quality of life of millions of people worldwide. The study's findings have the potential to provide a new treatment option for this disease, improving the lives of patients and their families.

Importance: The study is crucial because ME/CFS has no established cure, and existing treatments are often ineffective or have significant side effects. HBOT, a non-invasive and relatively safe treatment, has shown promise in previous studies, but its effectiveness and feasibility in ME/CFS patients have been largely unexplored. This study fills the research gap by investigating the effects of HBOT on ME/CFS patients, providing a new potential treatment option.

Timeliness: The study is timely because ME/CFS is a growing concern, with increasing awareness and recognition of its prevalence and severity. The study's findings have the potential to impact the lives of millions of people worldwide, making it a timely and relevant contribution to the field.

Relevance: The study's findings are relevant to the medical community, patients, and healthcare professionals. The study provides new insights into the effectiveness of HBOT in ME/CFS patients, highlighting its potential as a treatment option. The study's results also underscore the need for further research to confirm the therapeutic efficacy of HBOT in ME/CFS patients.

Usefulness for disease management or drug discovery: The study's findings are useful for disease management and potentially for drug discovery. The study provides a new treatment option for ME/CFS patients, which can improve their quality of life. The study's results also highlight the role of thalamic functional connectivity in ME/CFS pathophysiology, providing new insights for potential therapeutic targets.

Original information beyond the obvious: The study provides original information beyond the obvious by investigating the effects of HBOT on ME/CFS patients and highlighting its potential as a treatment option. The study's findings also provide new insights into the role of thalamic functional connectivity in ME/CFS pathophysiology, which can inform future research and potential therapeutic targets.

Relationship between items: The study's findings are related to each other in the following ways:

  • The improvement in physical functioning, fatigue, pain, and cognitive performance during HBOT is associated with significant reductions in thalamic hyperconnectivity.
  • The normalization of thalamic hyperconnectivity following HBOT is associated with clinical response, highlighting the role of thalamic functional connectivity in ME/CFS pathophysiology.
  • The study's findings provide a rationale for a controlled trial in ME/CFS to confirm the therapeutic efficacy of HBOT.

Usefulness of the text: The text is useful for several reasons:

  • It provides new insights into the effectiveness of HBOT in ME/CFS patients.
  • It highlights the potential of HBOT as a treatment option for ME/CFS patients.
  • It underscores the need for further research to confirm the therapeutic efficacy of HBOT in ME/CFS patients.
  • It provides a new understanding of the role of thalamic functional connectivity in ME/CFS pathophysiology.

Comparison with the state of the art: The study's findings are consistent with previous studies on HBOT in ME/CFS patients. However, the current study provides new insights into the effectiveness of HBOT and highlights its potential as a treatment option. The study's findings also provide a new understanding of the role of thalamic functional connectivity in ME/CFS pathophysiology, which can inform future research and potential therapeutic targets.

Read the original article on medRxiv

Chronic Adaptive versus Conventional Deep Brain Stimulation in Patients with Parkinson's Disease: A Randomized Crossover Trial with Exploratory Analysis of Baseline-Dependent Response Patterns

- Posted by system in English

Analysis of the Significance, Importance, Timeliness, and Relevance of the Topic

The topic of adaptive deep brain stimulation (aDBS) versus conventional DBS (cDBS) in Parkinson's disease patients is significant, important, and timely. Parkinson's disease is a chronic and debilitating neurodegenerative disorder affecting millions worldwide, and deep brain stimulation (DBS) is a established treatment option for motor symptoms. However, the current standard of care, cDBS, has limitations, particularly in its reliance on fixed stimulation parameters. The potential of aDBS to modulate stimulation based on real-time biomarkers offers a promising approach to improving treatment outcomes.

Breakdown of the Text and Relationships between Items

  1. Background: The text sets the context for the study, highlighting the limitations of cDBS and the potential of aDBS to offer advantages. It also notes the inconclusive evidence on aDBS efficacy under chronic stimulation.
  2. Objective: The objective of the study is clearly stated, aiming to compare the efficacy of aDBS versus cDBS under chronic stimulation in Parkinson's disease patients.
  3. Methods: The text describes the study design, including the double-blind, randomized crossover trial, patient selection, and stimulation protocols. The use of a dual-threshold algorithm to adjust amplitude in response to subthalamic beta-band LFP power is a key aspect of aDBS.
  4. Results: The results show no statistically significant differences between aDBS and cDBS across primary outcomes. However, exploratory analyses reveal heterogeneous directional effects, with some outcomes favoring aDBS and others favoring cDBS.
  5. Conclusions: The study concludes that aDBS and cDBS show comparable efficacy across clinical outcomes under chronic stimulation with optimized medication. The findings suggest that baseline clinical characteristics of patients may shape the results of aDBS, warranting larger trials to identify patient subgroups who may benefit from each stimulation approach.

Usefulness of the Text for Disease Management and Drug Discovery

While the study does not provide original information beyond the obvious, it contributes to the growing body of evidence on aDBS efficacy. The findings have implications for the management of Parkinson's disease, suggesting that aDBS may be a viable treatment option for certain patient subgroups. However, the study's limitations, including the small sample size and short trial duration, highlight the need for further research to fully understand the potential of aDBS.

Originality of Information

The study's findings are consistent with existing literature on aDBS, and the results are not surprising given the small sample size and exploratory nature of the study. However, the study's methodology and analysis are rigorous, and the conclusions are well-supported by the data. The text does not provide any new or groundbreaking information but rather contributes to the cumulative knowledge on aDBS efficacy.

Comparison with the State of the Art

The study's findings are consistent with existing studies on aDBS efficacy, which have reported mixed results. However, the study's use of advanced analysis techniques, such as mixed-effects analysis of covariance, and its focus on exploratory analyses to examine treatment-by-baseline interactions are novel aspects of the study. The study's findings highlight the need for larger trials to identify patient subgroups who may benefit from each stimulation approach, which is a key area of ongoing research in the field.

In conclusion, the text provides a well-structured and informative analysis of the efficacy of aDBS versus cDBS in Parkinson's disease patients. While the study does not provide original information beyond the obvious, it contributes to the growing body of evidence on aDBS efficacy and has implications for the management of Parkinson's disease.

Read the original article on medRxiv

Reduced brain entropy in migraine with partial restoration during attacks: A resting-state fMRI study

- Posted by system in English

Migraine is a prevalent and disabling neurological disorder, characterized by difficulties in regulating headache activity, sensory processing, and cognitive-emotional states. Brain entropy quantifies the complexity of neural dynamics, where reduced entropy may reflect diminished neural adaptability, but its assessment with fMRI in migraine remains limited. Here, we examined alterations in brain entropy and their associations with clinical burden, attack timing, and symptomatology. Resting-state fMRI data were acquired from adults with episodic migraine, chronic migraine, and healthy controls. Following standard preprocessing, voxel-wise sample entropy was computed, and group differences were assessed using ANCOVA with age and sex as covariates. Associations with clinical burden and symptom measures were examined within affected regions. In chronic migraine, attack timing-related changes in entropy were further explored, and the largest Lyapunov exponent (LLE) was estimated to characterize chaotic dynamics underlying attack-related complexity changes. Migraine patients showed reduced entropy in sensory, attentional, and default mode regions compared to controls, most pronounced in chronic migraine. Lower entropy correlated with greater headache frequency and longer illness duration. In chronic migraine, entropy relatively increased during attacks in multisensory integration regions and was associated with positive and elevated LLEs, indicating partially restored complexity with weakly chaotic dynamics. Patients experiencing phonophobia and nausea also exhibited increased entropy in multisensory and default mode regions. Our findings demonstrate widespread reductions in brain entropy in migraine, reflecting impaired neural adaptability, whereas attacks may transiently restore complexity partially through chaotic dynamics. These results advance understanding of migraine pathophysiology and highlight potential targets for therapeutic intervention.

Highlights- Migraine is marked by reduced brain entropy across sensory, attentional and default mode regions, which correlates with disease burden. - Reduced entropy reflects constrained neural adaptability within affected regions. - Migraine attacks transiently restore entropy, suggesting partial recovery of neural adaptability. - Positive and elevated Lyapunov exponents indicate a shift toward weakly chaotic dynamics during attacks. - Symptoms such as phonophobia and nausea are linked to increased entropy in multisensory integration and default mode regions.

Read the original article on medRxiv

Sex Differences in the Protective Effect of Brain Volume: Age Attenuates Protection in Females

- Posted by system in English

Significance of the Topic: The study examines the relationship between sex differences in outcomes after acute ischemic stroke (AIS) and several variables, including parenchymal brain volume (PBV), age, and final infarct volume (DWI-FIV). Understanding these mechanisms is crucial for developing targeted treatments and improving patient outcomes.

Importance: AIS is a leading cause of disability worldwide, and sex differences in outcomes have been well-documented. However, the underlying mechanisms remain unclear. This study provides valuable insights into the relationship between brain volume, age, and sex-specific differences in post-stroke disability, which can inform the development of personalized treatment strategies.

Timeliness: The study is timely as it builds upon existing research in the field of stroke and sex differences. The use of modern imaging techniques, such as automated pipelines for quantifying brain volume, allows for a more accurate and efficient analysis of the data.

Relevance: The study's findings have significant implications for disease management and drug discovery. The identification of sex-specific differences in the relationship between brain volume, age, and post-stroke disability can inform the development of targeted treatments and improve patient outcomes.

Analysis of the Text:

  • The study used a prospectively collected multicenter registry of AIS patients treated between 2015 and 2024, which provides a robust and representative sample.
  • Automated pipelines were used to quantify PBV and DWI-FIV, which ensures accuracy and efficiency in data analysis.
  • The study examined the relationship between PBV, age, and sex-specific differences in post-stroke disability, which provides valuable insights into the underlying mechanisms.
  • The findings suggest that PBV is protective in males but less so in females, where stronger age-related effects on infarct size and severity abrogate its benefit.
  • The study also highlights the importance of considering sex and brain volume measurements in outcome models.

Usefulness of the Text for Disease Management or Drug Discovery: The study provides valuable insights into the relationship between brain volume, age, and sex-specific differences in post-stroke disability, which can inform the development of targeted treatments. The findings suggest that sex-specific differences in the relationship between brain volume and post-stroke disability should be considered in the development of personalized treatment strategies.

Original Information Beyond the Obvious: The study provides new insights into the relationship between brain volume, age, and sex-specific differences in post-stroke disability. The findings suggest that PBV is protective in males but less so in females, where stronger age-related effects on infarct size and severity abrogate its benefit. This highlights the importance of considering sex and brain volume measurements in outcome models.

However, the study builds upon existing research in the field and does not present entirely new concepts. The findings are consistent with previous studies that have identified sex differences in outcomes after AIS, but the study provides a more comprehensive analysis of the underlying mechanisms.

Comparison with the State of the Art: The study is consistent with previous studies that have identified sex differences in outcomes after AIS. However, the study provides a more comprehensive analysis of the underlying mechanisms, including the relationship between brain volume, age, and sex-specific differences in post-stroke disability. The findings are also consistent with previous studies that have highlighted the importance of considering sex and brain volume measurements in outcome models.

Overall, the study provides valuable insights into the relationship between brain volume, age, and sex-specific differences in post-stroke disability, which can inform the development of targeted treatments and improve patient outcomes.

Read the original article on medRxiv


Please, help us continue to provide valuable information:

Useful Links

Quick Links

Get in Touch

Le Duzic, Hameau de la Goduçais, Le Minihic sur Rance, 35870, France

Contact the author